S
Su Jin Lim
Researcher at Samsung Medical Center
Publications - 3
Citations - 25
Su Jin Lim is an academic researcher from Samsung Medical Center. The author has contributed to research in topics: Hematopoietic stem cell transplantation & Transplantation. The author has an hindex of 3, co-authored 3 publications receiving 24 citations.
Papers
More filters
Journal ArticleDOI
Hematopoietic stem cell transplantation in children with acute leukemia: similar outcomes in recipients of umbilical cord blood versus marrow or peripheral blood stem cells from related or unrelated donors
Eun Sang Yi,Soo Hyun Lee,Meong Hi Son,Ju Youn Kim,Eun Joo Cho,Su Jin Lim,Hee Won Cheuh,Keon Hee Yoo,Ki Woong Sung,Hong Hoe Koo +9 more
TL;DR: Survival after UCB transplantation was similar to survival after MRD and URD transplantation, and for patients lacking an HLA matched donor, the use of UCB is a suitable alternative.
Journal ArticleDOI
Efficacy of Itraconazole Prophylaxis for Autologous Stem Cell Transplantation in Children with High-Risk Solid Tumors: A Prospective Double-Blind Randomized Study
Yae Jean Kim,Ki Woong Sung,Hye Sook Hwang,Shin Han Jung,Ju Youn Kim,Eun Joo Cho,Su Jin Lim,Young Bae Choi,Hee Won Cheuh,Soo Hyun Lee,Keon Hee Yoo,Hong Hoe Koo +11 more
TL;DR: Results were not sufficient to draw a definite recommendation about the routine use of antifungal prophylaxis in pediatric autologous HSCT recipients with high-risk solid tumors, but beneficial effects such as a shorter duration of fever and reduced need for antibiotic use were observed.
Journal ArticleDOI
Responses and adverse effects of carboplatin-based chemotherapy for pediatric intracranial germ cell tumors.
Suntae Ji,Hee Won Chueh,Ju Youn Kim,Su Jin Lim,Eun Joo Cho,Soo Hyun Lee,Keon Hee Yoo,Ki Woong Sung,Hong Hoe Koo +8 more
TL;DR: The current carboplatin-based chemotherapy protocol is safe and effective for the treatment of pediatric patients with IC-GCTs and it is concluded that no lethal hematological complications were associated with this treatment.